Latest news
Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:13:53 GMTAgomab Therapeutics (Nasdaq: AGMB) raises $208M IPO, funds pipeline to 2029 - Stock TitanStock Titan · Thu, 06 Aug 2026 20:07:36 GMTAgomab reports €252M cash and expects runway into H1 2029 - Stock TitanStock Titan · Thu, 06 Aug 2026 20:01:00 GMTWe're Not Very Worried About AgomAb Therapeutics' (NASDAQ:AGMB) Cash Burn Rate - MoomooMoomoo · Wed, 05 Aug 2026 16:19:51 GMTAgomAb Therapeutics (AGMB US): Synthetic Expert Call Transcript (05 Aug 2026) - SmartkarmaSmartkarma · Wed, 05 Aug 2026 13:03:57 GMTWe Think AgomAb Therapeutics (NASDAQ:AGMB) Can Afford To Drive Business Growth - simplywall.stsimplywall.st · Wed, 05 Aug 2026 11:15:37 GMTEnterprise value to revenue forward of AgomAb Therapeutics NV – NASDAQ:AGMB - TradingViewTradingView · Sat, 01 Aug 2026 07:02:38 GMTAGMB|AGMB.NB|Price:12.870|Chg%:+0.115 - TradingKeyTradingKey · Tue, 28 Jul 2026 01:45:34 GMT